martes, 17 de noviembre de 2015

FDA Law Blog: HP&M Attorneys Analyze ‘Recent Rift’ Between DEA and Its ALJs Regarding ALJ Deference in Latest Issue of FDLI Update Magazine

FDA Law Blog: HP&M Attorneys Analyze ‘Recent Rift’ Between DEA and Its ALJs Regarding ALJ Deference in Latest Issue of FDLI Update Magazine



Posted: 16 Nov 2015 07:03 PM PST
The latest issue of the Food and Drug Law Institute’s “Update” magazine features an article written by Hyman, Phelps & McNamara, P.C. attorneys John A. Gilbert, Jr. and Andrew J. Hull.  The article, titled “A Matter of Substantial Discretion: A Recent Rift Between DEA and Its ALJs Could Significantly Impact Registrants,” explores the issue of DEA’s deference to the factual findings and credibility determinations of its ALJs and how a recent trend by DEA to rely less on ALJ findings could significantly impact registrants. 

No hay comentarios: